Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
THALIDOMIDE FOR REFRACTORY ANGIODYSPLASIA-RELATED GASTROINTESTINAL BLEEDING IN A CONTINUOUS-FLOW LVAD RECIPIENT: A CASE REPORT
Anno:
2026
BACKGROUND: Gastrointestinal (GI) bleeding from intestinal angiodysplasia is a frequent complication of continuous-flow left ventricular assist device (CF-LVAD) support (≈25–30%). About 40% of patients develop recurrences, requiring rehospitalization and an elevated transfusion burden. Supraphysiologic shear stress and reduced pulsatility promote inflammatory/angiogenic mediators (TNF-α, VEGF), leading to maladaptive neovascularization and…
A CASE OF HEMODYNAMIC PULMONARY HYPERTENSION
Anno:
2026
A 44-year-old man presented to the emergency department with progressive dyspnea, peripheral edema, and fever lasting several days. He had no cardiovascular risk factors and had recently returned from Thailand. Initially admitted with suspected pneumonia, he rapidly developed hypotension and anuric acute kidney injury and was transferred to the…
CARDIOPULMONARY TESTING AS A VALUABLE TOOL FOR DIAGNOSIS, PROGNOSIS, AND TREATMENT GUIDANCE
Anno:
2026
Cardio-pulmonary exercise testing (CPET) is a well-known method but still relatively little used by cardiologists, both quantitatively and qualitatively. In fact, this application has been mistakenly limited to the assessment of heart failure, usually by observing only the numerical parameter of “peak oxygen consumption (PeakVO2)”. The latter is used…
BEYOND EJECTION FRACTION: CPET WITH NON-INVASIVE STROKE VOLUME AND HEART RATE RESERVE PREDICTS EXERCISE CAPACITY IN HEART FAILURE
Anno:
2026
BACKGROUND : Cardiopulmonary exercise testing (CPET) is the gold standard for the integrated assessment of cardiovascular, respiratory, and metabolic responses during exercise. In patients with heart failure (HF), peak oxygen uptake (pVO₂) and the VE/VCO₂ slope are well-established prognostic markers. Beyond these, dynamic parameters such as the variation of…
SAFE RENAL FUNCTION IN LONG TERM HEART TRANSPLANTED PATIENTS (SAREFU)
Anno:
2026
SA.RE.FU is a single-centre, prospective, randomized clinical trial which enrolled adult heart transplant patients in Hospital Papa Giovanni XXIII, Bergamo. The study began in 2007, with the aim to verify whether the reduction of cyclosporine dosages associated with everolimus administration may improve renal function as compared to patients maintained…
FROM FIRST DIAGNOSTIC EVALUATION TO NON-DILATED LEFT VENTRICULAR CARDIOMYOPATHY: THE ADDED VALUE OF CARDIAC MAGNETIC RESONANCE
Anno:
2026
Background: Non-dilated left ventricular cardiomyopathy (NDLVC) is a heterogeneous and evolving entity, recently recognized as a distinct category in the 2023 European Society of Cardiology (ESC) Guidelines. Cardiac magnetic resonance (CMR) enables a multiparametric assessment, with myocardial strain emerging as a key functional marker. However, genotype–phenotype correlations in NDLVC…
REVISITING THE 12 ML/KG/MIN THRESHOLD: CONTEMPORARY DATA CHALLENGE HEART TRANSPLANT CRITERIA
Anno:
2026
Background: Current guidelines recommend referring ambulatory heart failure (HF) patients for heart transplantation (HTX) when peak oxygen uptake (peak VO₂) is <12 mL/kg/min. This threshold, however, is based on decades-old data. As HF management has significantly improved, the relevance of this criterion in today’s clinical practice is uncertain. Methods:…
EFFICACY AND TOLERABILITY OF SACUBITRIL/VALSARTAN IN DUCHENNE DYSTROPHIC CARDIOMYOPATHY: A REAL-WORLD EXPERIENCE
Anno:
2026
Background Duchenne muscular dystrophy (DMD) is an X-linked hereditary neuromuscular disorder characterized by progressive muscular weakness and the development of a dystrophic cardiomyopathy. Despite standard therapy with ACE-inhibitors (ACEi), betablockers (BB) and mineralocorticoids receptor antagonists (MRA), the progression of left ventricular dysfunction remains one of the main causes of…
LEVOSIMENDAN IN PATIENTS WITH ADVANCED RENAL DYSFUNCTION: CLINICAL OUTCOMES AND TOLERABILITY IN A REAL-WORLD COHORT
Anno:
2026
Acute heart failure and cardiogenic shock are often associated with renal dysfunction. While Levosimendan can have beneficial hemodynamic effects, its off-label use in patients with eGFR<30 mL/min requires caution due to limited evidence. This study aimed to evaluate clinical outcomes and treatment tolerability of levosimendan according to renal function….
RELEVANCE OF RIGHT HEART IN PATIENTS RECEIVING MCS FOR ACUTE HEART FAILURE
Anno:
2026
Introduction : Acute heart failure (AHF) is the most common emergency admission in patients above 65 years old. Pulmonary hypertension (PH) is a very common finding in AHF patients. Due to the increase of the afterload, the right ventricle (RV) increases contractility to maintain its coupling with the pulmonary…